News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Avalon Pharmaceuticals (AVRX) Announces Special Meeting Date


4/29/2009 10:24:53 AM

GERMANTOWN, Md.--(BUSINESS WIRE)--Avalon Pharmaceuticals, Inc. (Nasdaq:AVRX), today announced that it has scheduled a special meeting of stockholders for Thursday, May 28, 2009, to consider and vote upon a proposal to adopt an agreement and plan of merger and reorganization, dated as of October 27, 2008, as amended, which provides for the acquisition of Avalon by Clinical Data, Inc (Nasdaq:CLDA). The proposed acquisition of Avalon by Clinical Data was previously announced on October 28, 2008.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES